Umoja
formerly Umoja BiopharmaPioneering immunotherapy by reprogramming T cells in vivo to target cancer cells and generate lasting remission.
Seattle, United States · Founded 2019 · $363.0M raised
- Headquarters
- Seattle, Washington
- Employees
- 201–500
- Founded
- 2019
- Business Model
- B2B
- Website
- umoja-biopharma.com
- Total Funding
- $363.0M
- Last Round
- $100.0M Series CJan 2025
- Rounds
- 4
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Umoja Biopharma is a clinical-stage biotechnology company pioneering in vivo CAR T cell therapy. Rather than manufacturing CAR T cells outside the body, Umoja's proprietary platform reprograms T cells inside patients, eliminating the costly and time-consuming ex vivo manufacturing process. The company's integrated technology platform is designed to make next-generation immunotherapy cost-effectively accessible to all cancer patients, including those who cannot benefit from current CAR T treatments. Umoja's pipeline targets solid tumors and hematologic malignancies.
Summary
Umoja is a Biotech company based in Seattle, United States, founded in 2019. It has raised $363.0M in total across 4 rounds, most recently a $100.0M Series C round in Jan 2025. Investors include DCVC (Data Collab), Cormorant Asset Management and MPM Capital.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2025
Sign up to see all 4 events
Funding: Seed through Series C. Amounts, valuations, and investors where available.
Investors
DCVC (Data Collab)
3 rounds
Cormorant Asset Management
2 rounds
MPM Capital
2 rounds
Double Point Ventures
1 round
SoftBank
1 round
Qiming Venture Partners USA
1 round
RTW Investments
1 round
Alexandria Venture Investments
1 round
ARK Invest
1 round
Perceptive Advisors
1 round
Vivo Capital
1 round
Acuta Capital Partners
1 round
Deerfield Management
1 round
TCGX
1 round
Similar Companies
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/umoja"><img src="https://indexed.vc/api/badge/company/umoja" alt="Umoja on Indexed.vc" width="260" height="76" /></a>